Omicron booster shots provide some protection against mild illness from Covid XBB subvariants, CDC says
Publishing timestamp: 2023-01-25 14:46:21
Summary
The CDC has published data showing that the omicron booster shots from Pfizer and Moderna reduce the risk of mild illness from the XBB subvariants of Covid-19. Protection varies by age, with adults ages 18-49 having 48% reduced risk of mild illness, and seniors having 42% reduced risk. Protection against severe illness is expected to be higher, though data is not yet available. The XBB.1.5 subvariant is quickly rising to dominance in the US, but the omicron booster shots provide similar protection against it as they do against the BA.5 subvariant.
Sentiment: POSITIVE
Keywords: breaking news: business, moderna inc, coronavirus, biotechnology, business news, health care industry, pfizer inc, epidemics, u.s. economy, pandemics, disease outbreaks, business, politics, biotech and pharmaceuticals,